Peer-influenced content. Sources you trust. No registration required. This is HCN.
Medical Professionals Reference (MPR)
The recent phase 1/2 study of Pfizer-BioNTech’s combination vaccine candidate demonstrated robust immune responses to influenza A, influenza B, and SARS-CoV-2 strains. This promising development could significantly impact global immunization practices.
Allergy & Immunology October 30th 2023
ACP Internist
Stay informed about the latest advancements in immunization practices. Learn more about the new FDA-approved RSV vaccines and their potential impact on patient care.
Family Medicine/General Practice October 11th 2023
ACIP’s endorsement of Abrysvo offers a new preventive measure against RSV in infants, urging healthcare providers to discuss this option with expectant parents.
Allergy & Immunology October 4th 2023
Stay ahead of the curve with the latest updates from the CDC and ACP on COVID-19 vaccinations and outpatient treatments, designed to prepare healthcare settings for the upcoming fall and winter season.
Clinical Pharmacology September 29th 2023
ReachMD
Addressing racial and ethnic disparities in flu vaccination is not just a public health issue; it’s a matter of social justice. Learn how you can be part of the solution.
All Specialties September 29th 2023
The FDA’s recent approval of updated Pfizer-BioNTech and Moderna COVID-19 vaccines marks a significant step in adapting to current viral variants. Stay informed and prepare to update vaccination protocols accordingly.
CME 
JOBS 
OUTBREAKS 
PEER-TO-PEER 
QUIZZES & QUESTIONS 
MEDTECH